Sinaptica Therapeutics at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

Sinaptica Therapeutics takes part in 1 session at CTAD 2026 in Boston. Its program presents its precuneus-directed TMS and EEG neuromodulation platform for Alzheimer's disease.

OrganizationCTAD 2026 Attendance
Sinaptica Therapeutics
Cambridge, Massachusetts
◇Silver Sponsor
sinapticatx.com
BiotechSilver Sponsor
Develops precuneus-targeted, EEG-guided transcranial magnetic stimulation as a treatment to slow memory and functional decline in Alzheimer's.
Talk
Tue Nov 17
12:14pm

Explore the full CTAD 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full CTAD 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Sinaptica Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction